Of note, evaluating the neuroprotective effects of SLAB51 oral supplementation on neuroinflammation in Alzheimer’s disease (AD), a recent study showed its ability to induce HIF-1α stabilization and to reduce the PHD2 expression, along with inhibition of NOS2 expression and activity in the brain of an AD animal model [31]. This evidence concerns the gene EGLN1 and Alzheimer disease.